ABN AMRO Bank intends to propose Marguerite Bérard as new CEO ABN AMRO Bank intends to propose Marguerite Bérard as new CEO 10 January 2025 ABN AMRO Bank has announced that it intends to propose Marguerite Bérard (1977) as new CEO. The proposed appointment of Marguerite Bérard is subject to regulatory approval. The bank has identified a suitable candidate to lead ABN AMRO into its next phase of growth and success. We have reached agreement with Marguerite Bérard with the aim of appointing her as ABN AMRO’s new CEO per 23 April 2025. Marguerite Bérard was the head of BNP Pa...
ABN AMRO is voornemens Marguerite Bérard voor te dragen als nieuwe CEO ABN AMRO is voornemens Marguerite Bérard voor te dragen als nieuwe CEO 10 januari 2025 ABN AMRO Bank maakt bekend dat de bank voornemens is Marguerite Bérard (1977) voor te dragen als nieuwe Chief Executive Officer (CEO). De voorgestelde benoeming van Marguerite Bérard is onder voorbehoud van goedkeuring van de toezichthouders. ABN AMRO heeft een geschikte kandidaat gevonden om de bank naar de volgende fase van groei en succes te leiden. De bank heeft overeenstemming bereikt met Marguerite Bérard met als doel haar ...
Ackermans & van Haaren: Nextensa might aim for ‘Proximus Towers' landmark project. D'Ieteren: Auto CEO sees Belgian new car market at 420k in 2025, down 6% YoY. Fastned: Preview of 4Q24 trading update. Proximus: HQ sale likely at price materially lower than expected. Randstad: 4Q24F results due 12 Feb, consensus released, negative earnings momentum. WDP: Sizeable acquisition in Belgium
We are hosting our 28th ODDO BHF Forum in Lyon on 9 and 10 January 2025. In total, 211 companies will be presenting over the two days. In the following note, we provide some initial feedback from the companies on day 1. Out of the 104 feedbacks collected during the first day, 40 were clearly positive, 59 rather Neutral, and only 6 negative. Among the positive names, we would particularly highlight Accor, URW, Euronext, Bureau Veritas, Renke, ID Logistics, Roche Bobois, Ionos, Companie des Alpes...
What's Cooking? announces the intent to purchase Sveltic in France. Sveltic has a broad range of frozen and chilled ready meals, complementary to the existing Ready Meals business strategy of What's Cooking? We see this as a first step in What's Cooking?'s intention to further invest in Ready Meals through organic growth and acquisitions. We increase our TP to €135 but lower our rating to Accumulate after the recent very strong share price performance.
Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference Daix (France), New York City (New York, United States), December 17, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), also known as non-alcoholic steatohepatitis (“NASH”), and other diseases with significant unmet medical needs, today announced that Frédéric Cren, CEO and cofounder of Inventiva, has been invited to prese...
Inventiva annonce sa participation à la « 43rd Annual J.P. Morgan Healthcare Conference » Daix (France), New York City (New York, Etats Unis), le 17 décembre 2024 – Inventiva (Euronext Paris and Nasdaq :IVA) (la « Société »), société biopharmaceutique spécialisée dans le développement clinique de petites molécules administrées par voie orale pour le traitement des patients atteints de stéatohépatite associée à un dysfonctionnement métabolique (« MASH »), également connue sous le nom de stéatohépatite non alcoolique (« NASH »), et d’autres maladies avec un besoin médical non satisfait, annon...
A director at Floridienne S.A. sold 2,000 shares at 510.000EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
Inventiva secures €21.4 million and completes the first tranche of the previously announced multi-tranche financing of up to €348 million Inventiva secures €21.4 million leading to completion of the first tranche of the financing for c. €116 million, part of the multi-tranche equity financing of up to €348 million announced on October 14, 2024. Proceeds from the completed first tranche to be primarily used to advance Inventiva’s Phase III, NATiV3 clinical trial evaluating lanifibranor in patients with MASH. Appointment of Mark Pruzanski as new Chairman of the Board...
Inventiva obtient 21,4 millions d'euros complétant la première tranche du financement multi-tranches annoncé précédemment d'un montant maximum de 348 millions d'euros Inventiva lève un montant de 21,4 millions d'euros permettant de compléter l’émission de la première tranche d’environ 116 millions d'euros du financement en fonds propres multi-tranches d'un montant maximum de 348 millions d'euros, annoncé le 14 octobre 2024. Le produit issu de cette première tranche finalisée du financement sera principalement utilisé pour faire progresser l'essai clinique de phase III, NATiV3, éva...
On this Friday the 13th we select for you 13 stocks to start 2025 with a bang : ABN Amro, Ackermans & van Haaren, Bekaert, D'Ieteren, EVS, Fagron, Fugro, Gimv, Melexis, Shurgard, Sofina, WDP and Xior However, we maintain a defensive stance in our Benelux selection at the start of 2025.. The long anticipated interest rate cuts by central banks are expected to continue their decline into 2025 (see graph above). However, the Trump election victory in the US hits European stocks even before he tak...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.